Evidence map›Paper›PMID 35206909›Full record

ArticleHealthcare (Basel, Switzerland)2022

Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey.

Sigrid Jehle-Kunz, Hans-Jörg Häuselmann, Mitra Keschawarzi, Olivier Lamy, Franck Luzuy, Natalie Marcoli, Christian Meier, Brigitte Uebelhart, Peter Wiedersheim

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sigrid Jehle-KunzCenter for Osteoporosis, St. Anna Clinic, 6003 Lucerne, Switzerland.
Hans-Jörg HäuselmannCenter for Rheumatology and Bone Diseases, 8038 Zurich, Switzerland.
Mitra KeschawarziMylan Pharma GmbH (a Viatris Company), 6312 Steinhausen, Switzerland.
Olivier LamyService of Internal Medicine, Department of Medicine, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0003-3684-2376
Franck LuzuyGynecology and Obstetrics, Clinic Grangettes-Hirslanden, 1224 Geneva, Switzerland.
Natalie MarcoliDepartment of Rheumatology, Regional Hospital of Lugano, 6962 Viganello, Switzerland.ORCID 0000-0002-0343-0765
Christian MeierDivision of Endocrinology, Diabetology and Metabolism, University Hospital, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0002-0619-821X
Brigitte UebelhartDivision of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.
Peter WiedersheimFMH Rheumatology, 9006 St. Gallen, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is the most common chronic metabolic bone disease, known to be underdiagnosed and undertreated in parts of the Swiss population. Due to expected rise in new fragility fractures, adequate awareness of associated risk factors and diagnostic and therapeutic options will be essential for the management of osteoporosis. We therefore explored these aspects in a nationwide survey of Swiss specialists and their patients. A total of 262 physician questionnaires and 9065 patient questionnaires were analyzed, mainly from general practitioners (64.9%), followed by rheumatologists (16.8%), gynecologists (12.2%), and endocrinologists (6.1%). Around 20% of patients were under medication and/or had a medical condition increasing the risk of osteoporosis. Further risk factors, such as low consumption of calcium-rich foods, smoking, elevated alcohol intake, and insufficient physical activity, were present across regions and medical fields. 53.9% of patients did not take calcium/vitamin D supplements; 3.5% reported having fragility fractures, and 7.3% received treatment for osteoporosis. Only 38.5% of surveyed patients knew of the chronic nature of osteoporosis, indicating rather low awareness in this population. Despite generally perceived relevance of osteoporosis for daily practice, aspects of its prevention and management varied across regions and medical fields. Raising awareness among patients and physicians will be vital for addressing osteoporosis on a national scale.

Indexed as

endocrinologistsfragility fracturesgeneral practitionersgynecologistsosteoporosisrheumatologistsrisk factorssupplementssurveySwitzerland

Identifiers

PMID35206909
PMCPMC8871550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.